Oriola (CHIX:ORIOLH) Future 3-5Y EPS without NRI Growth Rate: N/A (As of Aug. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:ORIOLH Oriola Corp CHIX:ORIOLH
39 GF Score
Price €0.94
GF Value €0.73
! 5 Warning Signs
View Full Analysis

What is Oriola Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Oriola's Future 3-5Y EPS without NRI Growth Rate is N/A.

Oriola  (CHIX:ORIOLh) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Oriola Future 3-5Y EPS without NRI Growth Rate Related Terms

Oriola Future 3-5Y EPS without NRI Growth Rate Competitor Comparison

For the Pharmaceutical Retailers subindustry, Oriola's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oriola Future 3-5Y EPS without NRI Growth Rate vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Oriola's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Oriola's Future 3-5Y EPS without NRI Growth Rate falls into.


CHIX:ORIOLH
39GF Score
Oriola Corp CHIX:ORIOLH
Future 3-5Y EPS without NRI Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Oriola (CHIX:ORIOLH) Overvalued in 2026?

Based on GuruFocus' analysis, Oriola stock appears to be overvalued. The current stock price of €0.94 is trading 28.5% above its estimated GF Value™ of €0.73.

Key valuation signals for CHIX:ORIOLH:

  • Future 3-5Y EPS without NRI Growth Rate: N/A
  • GF Value™: €0.73 vs. price of €0.94 (28.5% above fair value)
  • GF Score™: 39/100 with 5 warning signs

No single metric tells the full story. See the CHIX:ORIOLH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oriola Business Description

Address Orionintie 5, P.O. Box 8, Espoo, FIN, FI-02200
Oriola Corp is a health and wellbeing company operating in Nordic countries. It offers services such as the distribution of pharmaceuticals and other health and well-being products, services, and dose dispensing. Oriola's operations are divided into two segments which include distribution and wholesale. Geographically, the company operates in Sweden, Finland and other countries generating majority revenue from the region of Sweden.
39GF Score

Get the complete analysis for CHIX:ORIOLH

Future 3-5Y EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.94
Price
€0.73
GF Value